About TrialGPT
Patient recruitment is challenging for clinical trials. We introduce TrialGPT, an end-to-end framework for zero-shot patient-to-trial matching with large language models. TrialGPT comprises three modules: it first performs large-scale filtering to retrieve candidate trials (TrialGPT-Retrieval); then predicts criterion-level patient eligibility (TrialGPT-Matching); and finally generates trial-level scores (TrialGPT-Ranking). We evaluate TrialGPT on three cohorts of 183 synthetic patients with over 75,000 trial annotations. TrialGPT-Retrieval can recall over 90% of relevant trials using less than 6% of the initial collection. Manual evaluations on 1,015 patient-criterion pairs show that TrialGPT-Matching achieves an accuracy of 87.3% with faithful explanations, close to the expert performance. The TrialGPT-Ranking scores are highly correlated with human judgments and outperform the best-competing models by 43.8% in ranking and excluding trials. Furthermore, our user study reveals that TrialGPT can reduce the screening time by 42.6% in patient recruitment. Overall, these results have demonstrated promising opportunities for patient-to-trial matching with TrialGPT.

Proposed Overall Framework for Effective Patient-to-Trial Matching using Generative AI.
Our Team
Members from NLM | |
PI: | Zhiyong Lu, PhD |
Tech Lead: | Qiao Jin, MD |
Team Members: | Yifan Yang; Joey Chan; Nick Wan; Shubo Tian, PhD |
Collaborators from other NIH Institutes | |
NCI: | Charalampos S Floudas, MD DMSc MS; Dara Bracken-Clarke, MD; Elisabetta Xue, MD; James L. Gulley, MD PhD |
NEI: | Emily Chew, MD |
NICHD: | Christina Tatsi, MD MHSc PhD |
Collaborators from Organizations outside NIH | |
UIUC: | Zifeng Wang; Jimeng Sun, PhD |
Harvard: | Fangyuan Chen, MD |
Jacobi Medical Center: | Changlin Gong, MD |